Effect of early fatty acid status on neurodevelopmental outcome at 9 years.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON21520

Enrollment

457

Registered

2005-09-12

Start date

2005-04-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

typically developing children

Interventions

Standard infant formula enriched with 0.45 % AA and 0.30 % DHA.

Eligibility

Inclusion criteria

Inclusion criteria: Healthy term infants.

Exclusion criteria

Exclusion criteria: 1. A congenital disorder interfering with adequate functioning in daily life; 2. Children from multiple births; 3. Children whose mother did not master the Dutch language or suffered from significant illness or disability; 4. Adopted and fostered children; 5. Formula-fed infants who had received human milk for more than 5 days.

Design outcomes

Primary

Measure	Time frame
Neuromotor condition at 9 years.	—

Secondary

Measure	Time frame
Cognitive function at 9 years: 1. Attention and executive functions; 2. Language; 3. Memory and learning; 4. Behavioural problems.	—

Contacts

Public ContactM. Hadders-Algra

University Medical Center Groningen (UMCG) Beatrix Children's Hospital Developmental Neurology P.O. Box 30.001

m.hadders-algra@med.umcg.nl+31 (0)50 3614252

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)